Wedbush Morgan initiates coverage on Cadence Pharmaceuticals (Nasdaq: CADX) with a Buy.

Wedbush analyst says, "CADX is scheduled ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE